WEP CLINICAL ANNOUNCES PARTNERSHIP WITH PHARMING GROUP FOR EXPANDED ACCESS PROGRAM FOR LENIOLISIB Read More 8th June 2022
WEP CLINICAL PARTNERS WITH SELLAS LIFE SCIENCES GROUP TO LAUNCH EXPANDED ACCESS PROGRAM FOR GALINPEPIMUT-S Read More 4th May 2022
WEP CLINICAL PARTNERS WITH KINIKSA TO LAUNCH ARCALYST NAMED PATIENT PROGRAM Read More 17th August 2021
WEP CLINICAL EXECUTES MASTER SERVICES AGREEMENT WITH MEDLAB TO BRING NANABIS™ AND NANOCBD™ TO PATIENTS IN UK AND EUROPE VIA ETHICAL NAMED PATIENT PROGRAMMES Read More 19th July 2021
WEP CLINICAL EXPANDS AVAILABILITY OF XENLETA® (LEFAMULIN) NAMED PATIENT PROGRAM IN PARTNERSHIP WITH NABRIVA THERAPEUTICS Read More 25th March 2021
